Review of the "United Against Sepsis" Conference (9 September 2025)

IHU SEPSIS participated in the "United Against Sepsis" conference, organized by the European Society of Intensive Care Medicine (ESICM), the Belgian patient association Sepsibel, and the European consortium of patient associations, Sepsis Stronger Together.

Image
Bandeau_Evénement_UAS

Here is the professional English translation, structured to maintain a clean, readable layout for a report or newsletter:

On September 9, 2025, patients and healthcare professionals gathered in Brussels (Belgium) to raise awareness about sepsis and improve its management. Through rich and diverse presentations, the event addressed sepsis from a comprehensive standpoint, emphasizing:

  • The importance of early detection and prevention,
  • The need for unified guidelines and the development of national or European action plans to ensure prompt, adapted care,
  • The crucial role of post-sepsis follow-up, which is still all too often overlooked.

During the event, Professor Djillali Annane presented one of IHU SEPSIS’s flagship initiatives: a longitudinal cohort of adult and pediatric patients who survived sepsis. Planned over a ten-year period, this follow-up study aims to gain a deeper understanding of the challenges faced by survivors and their families, ultimately working to improve their quality of life.

Image
Diapo UAS
Image
Diapo UAS
Image
Diapo Djillali Annane
Image
Diapo Logos UAS

Challenges: No Awareness (I. Malfait), IHU SEPSIS (ex-PROMETHEUS) Cohort (D. Annane), UKST Survey - 2024 (O. Jones)

Latest news

How can rehabilitation be made clearer, more motivating, and more rewarding? This was the challenge at the heart of the HANDFUL workshop (HAnd-centric Neuromuscular Dexterity Training Interfaces for FUnctional Rehabilitation of Sepsis Patients' Limbs), conducted from October 2025 to April 2026 with...

Having earned her PhD in Microbiology in December 2025, Capucine reflects on her doctoral years at the IHU SEPSIS, within the Immunoanalysis Studies and Research Laboratory (LERI) of the Medicines and Healthcare Technologies Department (DMTS) at the CEA.